Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > I need to catch up

View:

Post by Edcando on Feb 26, 2021 9:40pm

I need to catch up

Lol. Up 160% opening day. Nice. So I noticed we've been fast tracked as we start our phase 1. Other bio plays I've been in its years between phase 1 and 3. Does anyone have even a rough idea of how long fast tracking (if successful and safe) leads to monetization?

#askingforaguywhoneedstopickupwaymoresharesmonday

449

Comment

Comment by Kobedog1 on Feb 26, 2021 10:37pm

Fast tracking in a Covid pandemic is breaking new ground. No one knows. Great deal of financial, political and social pressure everywhere throughout the world. This is new ice we all are skating on. That is my humble opinion. I believe there is no historical precedent to fall back on.

286

Comment

Comment by indaknownewfie on Feb 27, 2021 5:38pm

So from the Claritas website we see that they are partnering withbCMAx who have a 50 room facility. They are right on the grounds of Adelaide Hospital. This is what CMAX says. Indaknownewfie By using the Australian Clinical Trial Notification (CTN) scheme we fast-track your product into the clinic without the need to file an IND, saving you 6-9 months of time and money. Studies are initiated ...more

315

Comment